FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stent, Carotid

PMA: P030047 · Supplement: S049 · Decision Apr 4, 2025
Classifications
1
FEI Numbers
24
Registration Numbers
24

Basic Information

Device Name
Stent, Carotid
Trade Name
PRECISE PRO RX Transcarotid Stent System
PMA Number
P030047
Supplement Number
S049
Device Class
FDA Class 3
Product Code
NIM
Generic Name
Stent, carotid
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
April 4, 2025
Date Received
October 1, 2024
Supplement Type
Panel Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

The PRECISE® PRO Transcarotid Stent System used in conjunction with the ENROUTE® Transcarotid Neuroprotection System (NPS), is indicated for the treatment of patients at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below.1. Patients with neurological symptoms and >= 50% stenosis of the common or internal carotid artery by ultrasound or angiogram OR patients without neurological symptoms and >= 80% stenosis of the common or internal carotid artery by ultrasound or angiogram, AND2. Patients must have a vessel diameter of 4-9 mm at the target lesion,AND 3. Carotid bifurcation is located at minimum 5cm above the clavicle to allow for placement of the ENROUTE Transcarotid NPS.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIM Stent, Carotid